全文获取类型
收费全文 | 2792篇 |
免费 | 273篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 19篇 |
妇产科学 | 22篇 |
基础医学 | 1041篇 |
口腔科学 | 58篇 |
临床医学 | 113篇 |
内科学 | 476篇 |
皮肤病学 | 72篇 |
神经病学 | 144篇 |
特种医学 | 25篇 |
外国民族医学 | 1篇 |
外科学 | 100篇 |
综合类 | 227篇 |
预防医学 | 199篇 |
眼科学 | 26篇 |
药学 | 310篇 |
中国医学 | 151篇 |
肿瘤学 | 136篇 |
出版年
2024年 | 7篇 |
2023年 | 42篇 |
2022年 | 80篇 |
2021年 | 156篇 |
2020年 | 135篇 |
2019年 | 165篇 |
2018年 | 155篇 |
2017年 | 165篇 |
2016年 | 150篇 |
2015年 | 196篇 |
2014年 | 275篇 |
2013年 | 256篇 |
2012年 | 198篇 |
2011年 | 286篇 |
2010年 | 187篇 |
2009年 | 182篇 |
2008年 | 138篇 |
2007年 | 125篇 |
2006年 | 94篇 |
2005年 | 65篇 |
2004年 | 36篇 |
2003年 | 18篇 |
2002年 | 13篇 |
2001年 | 5篇 |
1998年 | 1篇 |
排序方式: 共有3130条查询结果,搜索用时 15 毫秒
51.
Nikki B. Marshall Ewa Lukomska Ajay P. Nayak Carrie M. Long Justin M. Hettick 《Journal of immunotoxicology》2017,14(1):50-59
The anti-microbial compound triclosan is incorporated into numerous consumer products and is detectable in the urine of 75% of the general United States population. Recent epidemiological studies report positive associations with urinary triclosan levels and allergic disease. Although not sensitizing, earlier studies previously found that repeated topical application of triclosan augments the allergic response to ovalbumin (OVA) though a thymic stromal lymphopoietin (TSLP) pathway in mice. In the present study, early immunological effects following triclosan exposure were further evaluated following topical application in a murine model. These investigations revealed abundant expression of S100A8/A9, which reportedly acts as an endogenous ligand for Toll-like Receptor 4 (TLR4), in skin tissues and in infiltrating leukocytes during topical application of 0.75–3.0% triclosan. Expression of Tlr4 along with Tlr1, Tlr2 and Tlr6 increased in skin tissues over time with triclosan exposure; high levels of TLR4 were expressed on skin-infiltrating leukocytes. In vivo antibody blockade of the TLR4/MD-2 receptor complex impaired local inflammatory responses after four days, as evidenced by decreased Il6, Tnfα, S100a8, S100a9, Tlr1, Tlr2, Tlr4 and Tlr6 expression in the skin and decreased lymph node cellularity and production of IL-4 and IL-13 by lymph node T-cells. After nine days of triclosan exposure with TLR4/MD-2 blockade, impaired T-helper cell type 2 (TH2) cytokine responses were sustained, but other early effects on skin and lymph node cellularity were lost; this suggested alternative ligands/receptors compensated for the loss of TLR4 signaling. Taken together, these data suggest the S100A8/A9-TLR4 pathway plays an early role in augmenting immunomodulatory responses with triclosan exposure and support a role for the innate immune system in chemical adjuvancy. 相似文献
52.
53.
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis 总被引:31,自引:0,他引:31
Rachmilewitz D Katakura K Karmeli F Hayashi T Reinus C Rudensky B Akira S Takeda K Lee J Takabayashi K Raz E 《Gastroenterology》2004,126(2):520-528
BACKGROUND & AIMS: We tested whether the attenuation of experimental colitis by live probiotic bacteria is due to their immunostimulatory DNA, whether toll-like receptor (TLR) signaling is required, and whether nonviable probiotics are effective. METHODS: Methylated and unmethylated genomic DNA isolated from probiotics (VSL-3), DNAse-treated probiotics and Escherichia coli (DH5 alpha) genomic DNA were administered intragastrically (i.g.) or subcutaneously (s.c.) to mice prior to the induction of colitis. Viable or gamma-irradiated probiotics were administered i.g. to wild-type mice and mice deficient in different TLR or in the adaptor protein MyD88, 10 days prior to administration of dextran sodium sulfate (DSS) to their drinking water and for 7 days thereafter. RESULTS: Intragastric and s.c. administration of probiotic and E. coli DNA ameliorated the severity of DSS-induced colitis, whereas methylated probiotic DNA, calf thymus DNA, and DNase-treated probiotics had no effect. The colitis severity was attenuated to the same extent by i.g. delivery of nonviable gamma-irradiated or viable probiotics. Mice deficient in MyD88 did not respond to gamma-irradiated probiotics. The severity of DSS-induced colitis in TLR2 and TLR4 deficient mice was significantly decreased by i.g. administration of gamma-irradiated probiotics, whereas, in TLR9-deficient mice, gamma-irradiated probiotics had no effect. CONCLUSIONS: The protective effects of probiotics are mediated by their own DNA rather than by their metabolites or ability to colonize the colon. TLR9 signaling is essential in mediating the anti-inflammatory effect of probiotics, and live microorganisms are not required to attenuate experimental colitis because nonviable probiotics are equally effective. 相似文献
54.
55.
56.
B cell-activating factor of the TNF family (BAFF) is an essential B cell survival factor. However, high levels of BAFF promote systemic lupus erythematosus (SLE) in mice and humans. Belimumab (anti-human BAFF) limits B cell survival and is approved for use in patients with SLE. Surprisingly, the efficacy of rituximab (anti-human CD20) in SLE remains controversial, despite depleting B cells more potently than belimumab. This raises the question of whether B cell depletion is really the mechanism of action of belimumab. In BAFF transgenic mice, SLE development is T cell-independent but relies on innate activation of B cells via TLRs, and TLR expression is modulated by the BAFF receptor TACI. Here, we show that loss of TACI on B cells protected against BAFF-mediated autoimmune manifestations while preserving B cells, suggesting that loss of BAFF signaling through TACI rather than loss of B cells may underpin the effect of belimumab in the clinic. Therefore, B cell-sparing blockade of TACI may offer a more specific and safer therapeutic alternative to broad B cell depletion in SLE. 相似文献
57.
目的:研究亚低温治疗对脑出血后大鼠Toll样受体4(toll-like receptor 4,TLR4)/核因子-κB(nuclear factor kappa B,NF-κB)介导的神经炎症反应的影响。方法:60只成年SD大鼠随机分为假手术组(Sham组)、脑出血模型组(ICH组)和亚低温治疗组(n=20)。采用自体血注入法复制大鼠脑出血模型,并给予亚低温干预。应用Berdson评分标准对各组大鼠进行神经功能评分,放射免疫法检测肿瘤坏死因子α(tumor necrosis factor-alpha,TNF-α)、白介素1β(interleukin-1beta,IL-1β)的含量;免疫组织化学法及免疫印迹法检测TLR4、NF-κB的蛋白表达情况。结果:与Sham组比,模型组大鼠神经功能评分明显增加(P0.05),TNF-α和IL-1β的含量明显升高(P0.05),血肿周围脑组织TLR4和NF-κB的表达显著上调(P0.05)。与模型组相比,亚低温治疗组大鼠神经功能评分显著减少(P0.05),TNF-α和IL-1β的含量明显降低(P0.05),TLR4和NF-κB蛋白的表达量显著下调(P0.05)。结论:亚低温治疗能通过调控TLR4/NF-κB表达,减轻大鼠脑出血后血肿周围脑组织的炎症反应,具有一定的神经保护作用。 相似文献
58.
59.
Gerónimo Fernández Ana Moraga María I. Cuartero Alicia García-Culebras Carolina Peña-Martínez Jesús M. Pradillo Macarena Hernández-Jiménez Silvia Sacristán M. Irene Ayuso Rafael Gonzalo-Gobernado David Fernández-López M. Elena Martín María A. Moro Victor M. González Ignacio Lizasoain 《Molecular therapy》2018,26(8):2047-2059
60.
《Vaccine》2015,33(32):3940-3946
BackgroundThis study aimed to investigate the dosage, immunogenicity and safety profile of a novel human papillomavirus (HPV) types 16 and 18 bivalent vaccine produced by E. coli.MethodsThis randomized, double-blinded, controlled phase 2 trial enrolled women aged 18–25 years in China. Totally 1600 eligible participants were randomized to receive 90 μg, 60 μg, or 30 μg of the recombinant HPV 16/18 bivalent vaccine or the control hepatitis B vaccine on a 0, 1 and 6 month schedule. The designated doses are the combined micrograms of HPV16 and 18 VLPs with dose ratio of 2:1. The immunogenicity of the vaccines was assessed by measuring anti-HPV 16 and 18 neutralizing antibodies and total IgG antibodies. Safety of the vaccine was assessed.ResultsAll but one of the seronegative participants who received 3 doses of the HPV vaccines seroconverted at month 7 for anti-HPV 16/18 neutralizing antibodies and IgG antibodies. For HPV 16, the geometric mean titers (GMTs) of the neutralizing antibodies were similar between the 60 μg (GMT = 10,548) and 90 μg (GMT = 12,505) HPV vaccine groups and were significantly higher than those in the 30 μg (GMT = 7596) group. For HPV 18, the GMTs of the neutralizing antibodies were similar among the 3 groups. The HPV vaccine was well tolerated. No vaccine-associated serious adverse events were identified.ConclusionThe prokaryotic-expressed HPV vaccine is safe and immunogenic in women aged 18–25 years. The 60 μg dosage formulation was selected for further investigation for efficacy.Clinical trials registration: NCT01356823. 相似文献